Ir al contenido principal

RSV vaccines must go to the right people

Plus more health news |

Email not displaying correctly? View it in your browser.
  
How to get RSV vaccines to those who need them most
By Oliver Staley
Heath Editor

In the wake of the rapid deployment and acceptance of COVID-19 vaccines, other, more specialized vaccines are now available. Among them are treatments for respiratory syncytial virus, or RSV, an illness that can affect the very young and the very old.

Unlike COVID vaccines, these new treatments are expensive, so it makes sense to first get them into the arms of those who need them most. As Dr. Elisabeth Rosenthal, the former editor-in-chief for KFF Health, writes in TIME, that’s what's happening in Europe, where policymakers can guide national health systems into making decisions that are good for both public health and public finances. As a result, they are prioritizing the health of infants, who are both more vulnerable to RSV and have many more years to live.

But, as Rosenthal points out, the U.S. lacks such government planning, and so the market takes the lead. Here, drug makers Pfizer and GlaxoSmithKline are marketing RSV vaccines to seniors, who are bombarded with ads for the shot on TV. The math for the companies is simple: There are 75 million older Americans who are eligible for the drug, and they don't need a prescription to get the shot, regardless of whether they're vulnerable to RSV or not. On the other hand, there are only 3.7 million infants born each year—and none of them are paying attention to ads on TV.

It doesn’t have to be this way, Rosenthal writes. As the pandemic effort shows, it’s possible to have a cohesive national vaccination strategy. But it requires leadership from policy makers.

READ MORE

Share This Story
What Else to Read
Why Diagnosing Alzheimer's Early Is So Important
By Alice Park
New data from Eli Lilly and Eisai show that their Alzheimer's drugs are more effective when started earlier in the disease progression.
Read More »
The Scientists Breaking AI to Make It Safer
By Billy Perrigo
To better guard against AI used to spread misinformation, scientists teamed up to train large language models at an event in London.
Read More »
How to Be Mindful if You Hate Meditating
By Angela Haupt
Put a puzzle together or listen to music.
Read More »
The Best Way to Break Up With Someone, According to Experts
By Jamie Ducharme
Ending a relationship is difficult, even if you're the one doing the dumping. (Originally published in 2018.)
Read More »
Do Massages Have Real Health Benefits?
By Markham Heid
The perks of a good massage are more than skin deep. (Originally published in 2018.)
Read More »
AN EXPERT VOICE

"Once babies are old enough, they should be eating the family meal, and maybe a vitamin if there's some type of deficiency. They don't need toddler beverages."

—Jennifer Pomeranz, associate professor of public health policy and management at New York University

If you were forwarded this and want to sign up to receive it daily, click here.

Today's newsletter was written by Oliver Staley and Haley Weiss, and edited by Angela Haupt.

 
 
 
 
 
 

Comentarios

Entradas populares de este blog

Stocks making the biggest moves midday: L Brands, Estee Lauder, CureVac, Tesla & more

Stocks making the biggest moves midday: L Brands, Estee Lauder, CureVac, Tesla & more This is a developing news story. Please check back for updates: https://www.cnbc.com/2020/08/20/stocks-making-the-biggest-moves-midday-l-brands-estee-lauder-curevac-tesla-more.html Follow @CNBCnow for breaking news and real-time market updates Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel   Digital Products Feedback Privacy Policy CNBC Events   © 2020 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 D

13 Foods That (Basically) Never Spoil

13 Foods That (Basically) Never Spoil Get the Magazine 13 Foods That (Basically) Never Spoil Read More »

Another S&P 500 record as month-end nears | Paypal to offer stock trading? | The end of the 20-year Afghanistan war

The S&P 500 set another record high on Monday as the market continued to rise in the final days of August. VIEW IN BROWSER | SUBSCRIBE MON, AUG 30, 2021 EVENING BRIEF   AS OF MON, AUG 30, 2021 • 04:51 ET DJIA 35399.84 -0.16% -55.96 S&P 500 4528.79 +0.43% +19.42 NASDAQ 15265.89 +0.90% +136.39   Most Active DOW NAME LAST CHG %CHG AAPL 153.12 +4.52 +3.04% MSFT 303.59 +3.87 +1.29% INTC